Subscribe to Daily Review - your favourite M&A deals update.

Submit Deal

Brad Bolzon

Chairman at VERSANT VENTURES

Investor

Deal Bio

Total Deals4

Valued Deals4

Total Value£ 2.10 B

Avg. Deal Size£ 524 M

Market Context

Sort

05 Aug 2021|United States|Biotechnology

Target: VIVIDION THERAPEUTICS

Bidder: BAYER AG

13 Service Providers

3 Target | 3 Bidder | 7 Vendor

47 Dealmakers

22 Target | 5 Bidder | 21 Vendor

£ 1.44 B

Value

15 Oct 2020|Switzerland|Biotechnology

Target: VECTIVBIO

Bidder: CORMORANT ASSET MANAGEMENT

16 Service Providers

3 Target | 13 Bidder

35 Dealmakers

16 Target | 21 Bidder

£ 84 M

Value

18 Aug 2020|Canada|Biotechnology

Target: CHINOOK THERAPEUTICS

Bidder: ECOR1 CAPITAL

18 Service Providers

5 Target | 13 Bidder

15 Dealmakers

2 Target | 13 Bidder

£ 80 M

Value

08 Aug 2019|United States|Biotechnology

Target: BLUEROCK THERAPEUTICS

Bidder: BAYER AG

4 Service Providers

1 Target | 2 Bidder | 1 Vendor

21 Dealmakers

2 Target | 16 Bidder | 3 Vendor

£ 493 M

Value

Explore deals beyond your search with a free MergerLinks account.

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy